Back to Search
DANIEL WEINTRAUB, BCBA
BCBA
Behavior Analyst
NPI: 1770120461Individual
Specialties, Licenses & Credentials
Behavior AnalystPrimary
Behavior Analyst
Code: 103K00000X
Clinical Trials (4)
4
Linked Trials
1
Recruiting
3
With Results
Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis
NCT04373317RECRUITINGPHASE4STUDY_CHAIR
Mild Cognitive Impairment in Parkinson's Disease
NCT01519271COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Effectiveness of Antidepressant Treatment for Depression in People With Parkinson's Disease
NCT00304161COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Naltrexone for Impulse Control Disorders in Parkinson's Disease
NCT01052831COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Research & Publications (2)
Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study.
PMID 25037206·Neurology·2014
2-rct
Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease.
PMID 20679638·Neurology·2010
2-rct
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1372 HAVEN GREEN CT
HENDERSON, NV 89012 - Phone
- (702) 572-4264
Quick Facts
- NPI
- 1770120461
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 4
- Publications
- 2
Are you this provider?
Claim Your Profile